• National Hospital Association Honors UTMB for COVID-19 Work

    America’s Essential Hospitals has recognized the University of Texas Medical Branch for its work to craft and continuously maintain a compendium of expert interpretive commentary regarding SARS-CoV-2 testing and a novel supporting technology that applies these comments and delivers them to physicians and patients.

  • Galveston Healing Arts Orchestra to hold concert

    The Galveston Healing Arts Orchestra will perform a classical concert at 7 p.m. June 24 in the Levin Hall Dining Room on the Galveston campus. The orchestra members include faculty, staff and students at UTMB.

  • UTMB researcher examines why U.S. health continues to lag behind

    Dr. Neil Mehta, an associate professor in epidemiology in the School of Public and Population Health at UTMB, is a guest editor of the special supplemental issue, Why is Health in the United States Continuing to Lag Behind? “There’s no simple answer,” Mehta said. “The issue touches on the many complicated factors with a focus on social and behavioral factors.”

  • UTMB Partners With UT El Paso To Improve Medical Imaging

    The University of Texas Medical Branch partners with UT El Paso on deep learning approach to improving lung region segmentation accuracy in chest x-ray images. The model is one of the first products created in partnership leveraging medical expertise at UTMB and computational expertise with machine learning and artificial intelligence at UT El Paso.

  • An image of a pill capsule full of gears

    UTMB drug discovery partnership awarded $56 million grant

    Thanks to a $56 million grant, the University of Texas Medical Branch and global health care company Novartis will enhance their work together to discover drugs to fight off the next pandemic. The grant comes from the National Institute of Allergy and Infectious Diseases (NIAID) and is one of nine such grants awarded by NIAID to establish Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

  • A man cluctching his chest during a heart attack

    Heart attack mortality rate higher in the US compared to other high-income countries

    When it comes to treating heart attacks, U.S. hospitals may have the latest tech and low readmission rates, but the country’s mortality rate is one of the highest among the nations included in a new study. The study, published May 4 in The BMJ, found substantial differences in care for heart attack patients across six high income countries despite international agreement on how heart attacks should be treated.

  • Therapy for Immunodeficiency Patients Shown to have anti-SARS-CoV-2 Antibodies

    Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community. The findings were recently published in the Journal of Allergy and Clinical Immunology.